An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of Coronavirus Disease-2019 (COVID-19), a respiratory disease, has infected almost one hundred million people since the end of 2019, killed over two million, and caused worldwide social and economic disruption. Because the mechanisms of SARS-CoV-2 infection of host cells and its pathogenesis remain largely unclear, there are currently no antiviral drugs with proven efficacy. Besides severe respiratory and systematic symptoms, several comorbidities increase risk of fatal disease outcome. Therefore, it is required to investigate the impacts of COVID-19 on pre-existing diseases of patients, such as cancer and other infectious diseases. In the current study, we report that SARS-CoV-2 encoded proteins and some currently used anti-COVID-19 drugs are able to induce lytic reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV), one of major human oncogenic viruses, through manipulation of intracellular signaling pathways. Our data indicate that those KSHV + patients especially in endemic areas exposure to COVID-19 or undergoing the treatment may have increased risks to develop virus-associated cancers, even after they have fully recovered from COVID-19. Chen et al. find that SARS-CoV-2 encoded proteins and some anti-COVID-19 drugs can induce lytic reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV), one of the major human oncogenic viruses. This study suggests that KSHV-positive patients exposed to COVID-19 or undergoing its treatment may have increased risks to develop virus-associated cancers, even after they have fully recovered from COVID-19.
【저자키워드】 Virology, Infection, 【초록키워드】 COVID-19, Treatment, coronavirus disease, viruses, SARS-CoV-2, Efficacy, coronavirus, Infectious diseases, Diseases, Pathogenesis, SARS-COV-2 infection, Cancer, antiviral drugs, Comorbidity, risk, drug, outcome, Symptoms, antiviral drug, Novel coronavirus, coronavirus disease-2019, outbreak, cancers, Impact, Respiratory disease, Patient, respiratory, disease, patients, mechanism, Pathways, host cells, exposure to, host cell, causative agent, other infectious diseases, increased risk, novel coronavirus SARS-CoV-2, encoded proteins, manipulation, fatal disease, intracellular signaling, endemic area, develop, caused, required, induce, encoded protein, oncogenic, 【제목키워드】 drug, virus, SARS-CoV-2 protein, induce, oncogenic,